
Cerus Corp CERS.OQ reported a quarterly adjusted loss of 1 cent per share for the quarter ended December 31, identical to the same quarter last year. The mean expectation of six analysts for the quarter was for a loss of one cent per share. Wall Street expected results to range from -2 cents to -1 cents per share.
Revenue rose 8.6% to $50.81 million from a year ago; analysts expected $49.64 million.
Cerus Corp's reported EPS for the quarter was a loss of 1 cent.
The company reported a quarterly loss of $2.52 million.
Cerus Corp shares had risen by 17.5% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 12.5% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Cerus Corp is $4.00
This summary was machine generated from LSEG data February 20 at 10:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2024 | -0.01 | -0.01 | Met |
Sep. 30 2024 | -0.03 | -0.02 | Beat |
Jun. 30 2024 | -0.04 | -0.03 | Beat |
Mar. 31 2024 | -0.05 | -0.05 | Met |